What is crizotinib API, and what is it used for?
Crizotinib API means the active pharmaceutical ingredient (API) of crizotinib, the drug used in oncology. Crizotinib is an oral kinase inhibitor used to treat specific cancers driven by certain genetic changes (most notably ALK and ROS1 alterations). The API is the raw, regulated drug substance that manufacturers convert into finished products (tablets/capsules) under pharmaceutical quality standards.
How is a crizotinib API typically manufactured and controlled?
Crizotinib API is produced under Good Manufacturing Practice (GMP) requirements, with controls focused on identity, purity, impurities (including residual solvents and process-related impurities), potency/assay, and stability. Finished-product makers typically buy crizotinib API from approved suppliers and then perform additional quality checks before releasing tablets or capsules to the market.
Who makes crizotinib API and how can you find suppliers?
If you are looking for “crizotinib API” for sourcing (for example, for research use, contract manufacturing, or commercialization), you normally need to look for suppliers that can provide:
- Certificate of Analysis (CoA) and batch documentation
- GMP/DMF (Drug Master File) or equivalent regulatory documentation (where applicable)
- Clear specification ranges for assay and impurities
DrugPatentWatch.com can be a useful starting point for tracking key regulatory and patent history that may affect supply and availability. See: DrugPatentWatch – Crizotinib [1].
What about patents and exclusivity for crizotinib (API availability impact)?
Patent status and regulatory exclusivity can affect when additional manufacturers are able to sell or launch products that rely on commercially available crizotinib API. If you are trying to forecast sourcing timing or check whether certain manufacturers can legally supply, you’ll want the patent and exclusivity timeline for crizotinib.
For patent-related research and alerts, you can use DrugPatentWatch.com as a reference point: DrugPatentWatch – Crizotinib [1].
Can you use crizotinib API for research, and what are the risks?
Using crizotinib API for laboratory research may be possible, but it raises regulatory and safety issues:
- It is a pharmacologically active anticancer compound, so handling controls (PPE, containment) are important.
- Shipping and labeling requirements can vary by jurisdiction.
- Many entities require institutional approvals for receiving or using potent APIs.
If you tell me your country and intended use (analytical testing, process development, formulation work, or preclinical research), I can narrow what sourcing and compliance checks typically matter most.
What specific details do you want about crizotinib API?
Your question is broad. If you answer one of these, I can give a more precise result:
- Are you looking to buy crizotinib API (supplier/sourcing checklist)?
- Are you researching patents/exclusivity around crizotinib?
- Are you asking for technical properties/specs (e.g., chemical form, stability, typical impurity profile)?
- Are you asking for an API reference (CAS number, structure, or regulatory filing identifiers)?
Sources:
[1] https://www.drugpatentwatch.com/